发明名称 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
摘要 The present invention relates to a novel form of core+1 protein of Hepatitis C virus (HCV), designated shorter form core+1 protein. The shorter form core+1 protein of Hepatitis C virus is the product of translation of a coding sequence consisting of all or part of a nucleotide sequence extending from nucleotide 598 to nucleotide 920 within the core+1 ORF of HCV represented on FIG. 3B. The invention also provides methods for detecting infection by Hepatitis C virus in biological samples, methods of screening compounds which interact with viral propagation in HCV infected cells or screening of compounds impaction on the expression of shorter form core+1 protein and uses of these compounds for the preparation of compositions useful for their anti-viral activities.
申请公布号 US2011287406(A1) 申请公布日期 2011.11.24
申请号 US20100926387 申请日期 2010.11.15
申请人 MAVROMARA PENELOPE;VASSILAKI NIKI;INSTITUT PASTEUR HELLENIQUE;INSTITUT PASTEUR 发明人 MAVROMARA PENELOPE;VASSILAKI NIKI
分类号 C12Q1/70;C07H21/04;C07K5/103;C07K7/08;C07K14/18;C07K16/10;C07K16/40;C12N5/10;C12N15/51;C12N15/63;G01N33/53;G01N33/576 主分类号 C12Q1/70
代理机构 代理人
主权项
地址